Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
There was a burst of activity from Chinese pharmaceutical and biotechnology companies in the equity capital markets this week, as the sector took centre stage following the spread of a flu-like virus that has already claimed lives on the mainland. Jonathan Breen reports. -
Chinese biopharmaceutical company Zai Lab has kicked off a follow-on offering of its American Depository Shares. It is aiming to raise around $300m.
-
Intu, the British real estate and investment trust focused on shopping centres, has confirmed it will be tapping its shareholders for equity capital in February, but sources say the company needs to outline its vision for its future, given the headwinds buffeting the UK retail sector.
-
Chinese real estate developer Beijing Capital Land has raised HK$925.3m ($119.1m) from the H-share portion of a three-tranche rights issue.
-
Guotai Junan International Holdings is planning a rights issue of new shares as it looks to raise up to HK$3.75bn ($482.3m).
-
Chinese property developer Seazen Group raised HK$2.73bn ($351.3m) on Monday from a sale of new shares, increasing the offering size on the back of strong demand, according to a source familiar with the deal.
